Search
Search Results
##search.searchResults.foundPlural##
-
Skin Manifestations associated with Mantle cell Lymphoma: a case report
1624PDF: 801HTML: 2184Untitled: 249Untitled: 221Untitled: 210Untitled: 229Untitled: 225 -
TOXICITIES ASSOCIATED WITH CAR-T CELL THERAPIES CAR-T Cell Toxicity
2594PDF: 1744HTML: 534 -
DEFERASIROX: OVER A DECADE OF EXPERIENCE IN THALASSEMIA
3156PDF: 1653HTML: 366 -
PROGNOSTIC FACTORS IN HODGKIN LYMPHOMA
3445PDF: 2042HTML: 7573 -
THALASSEMIA AND VENOUS THROMBOEMBOLISM
3029PDF: 1141HTML: 4675 -
HIV INFECTION, ANTIRETROVIRAL THERAPY AND CARDIOVASCULAR RISK
1934PDF: 825HTML: 3689 -
IMPORTANCE OF HYPERBILURUBINEMIA IN DIFFERENTIATION OF PRIMARY AND SECONDARY HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS IN PEDIATRIC CASES
1844PDF: 971HTML: 1197Untitled: 184Untitled: 203Untitled: 191Untitled: 185 -
THALIDOMIDE AMELIORATES ERYTHROPOIESIS AND IRON HOMEOSTASIS IN TRANSFUSION-DEPENDENT β-THALASSEMIA Thalidomide ameliorates erythropoiesis and iron homeostasis
1501PDF: 1470PDF: 1045HTML: 231 -
Kikuchi-Fujimoto disease and hemophagocytic lymphohistiocytosis: a rare combination of two rare diseases
972PDF: 711Suppl. Files: 142HTML: 151 -
-
DIAGNOSIS AND SUBCLASSIFICATION OF ACUTE LYMPHOBLASTIC LEUKEMIA
9327PDF: 6205HTML: 88074Fig.1b: 221Fig.1c: 222Fig.2a: 205Fig.2b: 204Fig.4: 226Fig.2c: 206Fig.3: 208Tab.1: 262Tab.2: 240Tab.3: 223Tab.4: 254Fig1a: 219 -
IMMUNOTHERAPY FOR EPSTEIN-BARR VIRUS-RELATED LYMPHOMAS
1274PDF: 625HTML: 6918 -
CHIMERIC ANTIGEN RECEPTOR T CELLS FOR THE TREATMENT OF MULTIPLE MYELOMA CAR T Cells and Myeloma Treatment
1851PDF: 909HTML: 1473 -
Common variable immunodeficiency due to a novel NFKB1 variant in a child with thalassemia major CVID with thalassemia major
785PDF: 596HTML: 193 -
ASSOCIATION BETWEEN PRE-ADMISSION 48-HOUR FEVER BURDEN AND OUTCOMES IN PEDIATRIC MYCOPLASMA PNEUMONIAE INFECTION PRE-ADMISSION 48-HOUR FEVER BURDEN AND OUTCOMES IN PEDIATRIC MYCOPLASMA PNEUMONIAE
240PDF: 368Suppl. Files: 63HTML: 124 -
NEW TREATMENTS FOR MYELODYSPLASTIC SYNDROMES
2083PDF: 1607HTML: 804 -
THERAPY-RELATED MYELOID NEOPLASMS: PREDISPOSITION AND CLONAL EVOLUTION T-AML predisposition
1480PDF: 961HTML: 253 -
CONCISE REVIEW ON THE FREQUENCY, MAJOR RISK FACTORS AND SURVEILLANCE OF HEPATOCELLULAR CARCINOMA (HCC) IN ?-THALASSEMIAS: PAST, PRESENT AND FUTURE PERSPECTIVES Thalassaemia transfusion dependent, Hepatitis C, hepatocarcinoma.
4378PDF: 1566HTML: 470 -
The association of rheumatoid arthritis with glucose- 6-phosphate dehydrogenase deficiency—results from a case-control study. G6PD and Rheumatoid Arthritis
1263PDF: 881HTML: 113 -
IMMUNOGLOBULIN GENE REPERTOIRE IN CHRONIC LYMPHOCYTIC LEUKEMIA: INSIGHT INTO ANTIGEN SELECTION AND MICROENVIRONMENTAL INTERACTIONS
3193PDF: 925HTML: 7303Kost Fig1: 211Kost Fig 2: 198Kost Fig3: 204Kost Fig 4: 216Kost Fig5: 215Kost fig 6: 202 -
Status Epilepticus Due to Severe HHV-6 Encephalitis in an Allogeneic Stem Cell Transplant Recipient
1230PDF: 862HTML: 2191Figue 1: 191 -
CAR-T CELLS IN CHRONIC LYMPHOCYTIC LEUKEMIA CAR-T and CLL
3869PDF: 1687HTML: 89 -
TARGETING DORMANT BACILLI TO FIGHT TUBERCULOSIS
3154PDF: 1052HTML: 3191 -
STUDY OF SERUM HAPTOGLOBIN LEVEL AND ITS RELATION TO ERYTHROPOIETIC ACTIVITY IN BETA THALASSEMIA CHILDREN .
2342PDF: 1201HTML: 2606Study of serum haptoglobin level in thalassemia: 384Figures: 210 -
EARLY PREDICTIVE VALUE OF PERIPHERAL INFLAMMATORY INDEX COMBINED WITH HIGH-SENSITIVITY TROPONIN T FOR SEPSIS-INDUCED CARDIOMYOPATHY Inflammatory and Troponon T in cardiomyopaty from Sepsis
359PDF: 380HTML: 112 -
LYON-UNIVERSITY HOSPITAL EXPERIENCE WITH GEMTUZUMAB OZOGAMICIN THERAPY IN ACUTE MYELOID LEUKEMIA: A ‘REAL-LIFE’ STUDY Gemtuzumab ozogamicin in AML
1946PDF: 1204HTML: 337 -
-
-
A A RETROSPECTIVE LONG-TERM STUDY ON AGE AT MENARCHE AND MENSTRUAL CHARACTERISTICS IN 85 YOUNG WOMEN WITH TRANSFUSION-DEPENDENT Β-THALASSEMIA (TDT) BORN BETWEEN 1965 AND 1995 Long-Term Study on Age at Menarche and Menstrual Characteristics in patients with TDT
1626PDF: 543HTML: 267 -
DISSEMINATED HISTOPLASMOSIS AS AIDS PRESENTATION. CASE REPORT AND COMPREHENSIVE REVIEW OF CURRENT LITERATURE
3899PDF: 1347HTML: 903Figure 2: 483Figure 1: 3166 -
The ASSOCIATED FACTORS ON CYTOMEGALOVIRUS REACTIVATION OF CRITICALLY ILL IMMUNOCOMPETENT PATIENTS Cytomegalovirus Reactivation of Critically Ill Patients.
207PDF: 198HTML: 16 -
Anemia in the elderly: not always what it seems.
3381PDF: 1114HTML: 1799Figure 1: 208Figure 1 revised: 204







